Quantcast

Latest ATryn Stories

2008-10-06 09:00:57

OVATION Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ATryn(R) (antithrombin alfa). OVATION acquired the exclusive U.S.

2008-09-19 06:00:09

By Elizabeth Weise After more than seven years of discussion, the Food and Drug Administration proposed regulations Thursday that would allow the commercial use of genetically engineered animals.

2008-09-05 09:00:37

GTC Biotherapeutics, a developer of recombinant blood proteins, has announced that the FDA has assigned priority review to the company's biologic license application for ATryn.

2008-09-04 09:00:48

The US Food and Drug Administration, or FDA, has assigned Priority Review to GTC Biotherapeutics, Inc.'s ("GTC", Nasdaq: GTCB) Biologic License Application, or BLA, for ATryn(R).

2008-08-14 09:01:15

GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced the closing of its previously announced collaboration agreement with OVATION Pharmaceuticals, Inc. ("OVATION") to develop and market ATryn(R) in the United States.

2008-08-14 09:01:14

OVATION Pharmaceuticals, Inc. announced today that it has completed its previously announced transaction to obtain the exclusive license for the commercialization and development of GTC Biotherapeutics' ATryn(R) (antithrombin alfa) in the United States.

2008-08-07 15:01:00

GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) has completed its submission of the final portion of the Biologics License Application, or BLA, for ATryn(R) in the United States.

2008-08-07 09:01:06

GTC Biotherapeutics, Inc.'s ("GTC", Nasdaq: GTCB) total net loss for the second quarter ended June 29, 2008, was $2.2 million, or $0.02 per share, compared with a net loss of $10.6 million, or $0.14 per share, for the second quarter of 2007.

2006-06-02 08:15:00

By Ben Hirschler, European Pharmaceuticals Correspondent LONDON (Reuters) - The world's first medicine derived from a genetically engineered animal has been recommended for approval by a panel of European experts, following a re-examination of the evidence.

2006-06-02 08:00:00

By Ben Hirschler, European Pharmaceuticals Correspondent LONDON (Reuters) - The world's first medicine derived from a genetically engineered animal has been recommended for approval by a panel of European experts, following a re-examination of the evidence.


Word of the Day
plim
  • To swell, as grain or wood with water.
The word 'plim' is probably a variant of the word 'plum'.
Related